Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,600
Closed -$329K 989
2021
Q4
$329K Hold
9,600
﹤0.01% 901
2021
Q3
$524K Sell
9,600
-500
-5% -$30.1K 0.01% 847
2021
Q2
$742K Sell
10,100
-2,600
-20% -$260K 0.01% 822
2021
Q1
$1.16M Buy
+12,700
New +$1.23M 0.02% 742

Other funds holding CVAC

Utah Retirement Systems's CVAC Position: Q1 2022 in Review

Utah Retirement Systems sold out of CureVac (CVAC) in Q1 2022, closing a stake of 9,600 shares — an estimated $329K sold.

Utah Retirement Systems first reported a position in CVAC in Q1 2021 and held it in 4 quarters. The position peaked at $1.16M in Q1 2021. 111 funds tracked by Wall St. Rank hold CVAC as of Q1 2022.

  • Utah Retirement Systems reported no remaining CureVac position as of Q1 2022 after selling out during the quarter.
  • Utah Retirement Systems sold 9,600 CureVac shares in Q1 2022, an estimated $329K.
  • Utah Retirement Systems first reported a position in CureVac in Q1 2021 and held it in 4 quarters.
  • Utah Retirement Systems's CureVac position peaked at $1.16M in Q1 2021.
  • 111 funds tracked by Wall St. Rank held CureVac as of Q1 2022.

Based on Utah Retirement Systems's 13F filing for Q1 2022, filed 13 May 2022.